Barbara Mandriani

Bari, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

SPINK2 silencing suppresses leukemic proliferation and restores myeloid commitment via MECOM downregulation in acute myeloid leukaemia.

SPINK2 silencing suppresses leukemic proliferation and restores myeloid commitment via MECOM downregulation in acute myeloid leukaemia.

Journal: Cell death discovery
Published: October 14, 2025

Heterozygous variants in PLCG1 affect hearing, vision, cardiac, and immune function.

Heterozygous variants in PLCG1 affect hearing, vision, cardiac, and immune function.

Journal: eLife
Published: August 27, 2025

Heterozygous variants in PLCG1 affect hearing, vision, cardiac, and immune function.

Heterozygous variants in PLCG1 affect hearing, vision, cardiac, and immune function.

Journal: medRxiv : the preprint server for health sciences
Published: January 23, 2024

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML.

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML.

Journal: Cell death & disease
Published: July 27, 2023

Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors.

Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors.

Journal: Journal for immunotherapy of cancer
Published: June 01, 2022

Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications.

Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications.

Journal: Frontiers in oncology
Published: June 01, 2022

The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability.

The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability.

Journal: Journal of neuroendocrinology
Published: July 16, 2021

Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives.

Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives.

Journal: Cancer treatment reviews
Published: April 30, 2021

The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors.

The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors.

Journal: Current treatment options in oncology
Published: July 27, 2019

DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors.

DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors.

Journal: Scientific reports
Published: April 03, 2019

Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains.

Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains.

Journal: Science advances
Published: July 25, 2018

Dissecting KMT2D missense mutations in Kabuki syndrome patients.

Dissecting KMT2D missense mutations in Kabuki syndrome patients.

Journal: Human molecular genetics
Published: April 24, 2018
Showing 1-12 of 24

Last Updated: 09/26/2026